Biotech Growth Investors & VC Firms
708 firms in this list, with a median first check of $1M. 169 of them lead rounds. Generated from verified public data and updated continuously.
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
GSR United Capital
BeijingSeed–Growth
Mérieux Equity Partners
ParisSeed–Growth$3.2M – $86M
14 people
America's Frontier Fund
ArlingtonSeed–Growth$500K – $10M
13 people
Bioventures Investors
WestboroughSeed–Growth$15M – $100M
16 people
Finance Yorkshire
BarnsleySeed–Growth
22 people
Perscitus LLP
LondonPre-Seed–Late Stage
10 people
Merida Capital Holdings
RyeGrowth
6 people
Quadrille Capital
ParisSeed–Late Stage
15 people
Scottish Mortgage Investment Trust PLC
EdinburghSeed–Late Stage
18 people
CITIC Capital Holdings
Hong KongGrowth–Late Stage
20 people
Expon Capital
LuxembourgSeed–Growth$550K – $1.6M
5 people
Kernel Capital
CorkSeed–Growth$1.1M – $5.4M
10 people
Owl Rock Capital
New YorkGrowth–Late Stage
14 people
Bridge Bank
San FranciscoSeed–Late Stage
16 people
Intermediate Capital Group
LondonGrowth–Late Stage$5M – $50M
16 people
Kelvin Capital
GlasgowSeed–Growth
10 people
Bonitás Ventures
BudapestGrowth–Late Stage$540K – $4.3M
18 people
Vertex Venture Management Pte. Ltd.
SingaporeSeed–Growth
21 people
Trans-Pacific Technology Fund
TaipeiSeed–Growth
17 people
Breakthrough Victoria
MelbournePre-Seed–Growth
7 people
IRDI SORIDEC Gestion
ToulouseSeed–Late Stage$216K – $16.2M
17 people
Kobe University Capital
KobePre-Seed–Growth
10 people
PAI Partners
ParisGrowth–Late Stage$108M – $324M
13 people
Related lists
Growth Investors & VC Firms (4263)Biotech Investors & VC Firms (2475)Growth Investors & VC Firms in North America (2121)Biotech Seed Investors & VC Firms (2020)Growth Investors & VC Firms in United States (1837)Growth Investors & VC Firms in Europe (1633)Biotech Series A Investors & VC Firms (1626)Biotech Investors & VC Firms in North America (1594)Biotech Investors & VC Firms in United States (1445)Growth Investors & VC Firms in Global (1377)
Data sourced from public filings and firms' own websites — see our methodology.















































































/f/233941/5455x4091/3b9777c68f/chow-shangwei.jpg)


















